Pharming (PHAR) Intangibles (2019 - 2025)
Pharming's Intangibles history spans 7 years, with the latest figure at $135.5 million for Q4 2025.
- Quarterly results put Intangibles at $135.5 million for Q4 2025, up 122.05% from a year ago — trailing twelve months through Dec 2025 was $135.5 million (up 122.05% YoY), and the annual figure for FY2025 was $135.5 million, up 122.05%.
- Intangibles for Q4 2025 was $135.5 million at Pharming, up from $61.0 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $135.5 million in Q4 2025 to a low of $61.0 million in Q4 2024.
- The 5-year median for Intangibles is $75.1 million (2022), against an average of $85.4 million.
- The sharpest move saw Intangibles dropped 14.35% in 2024, then skyrocketed 122.05% in 2025.
- Year by year, Intangibles stood at $83.8 million in 2021, then decreased by 10.39% to $75.1 million in 2022, then dropped by 5.13% to $71.3 million in 2023, then dropped by 14.35% to $61.0 million in 2024, then skyrocketed by 122.05% to $135.5 million in 2025.
- According to Business Quant data, Intangibles over the past three periods came in at $135.5 million, $61.0 million, and $71.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.